IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia
Article in Frontiers in Oncology (April 2024)
The most recent citing publications are shown below. View all 125 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (April 2024)
Article in Cell Genomics (March 2024)
Article in Cancer Epidemiology (February 2024)